References
- Wilfert CM. Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Infect Dis 1994; 19(4):664–6
- Public Health Service. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987; 36(31):509–15
- Children born to women with HIV-1 infection: natural history and risk of transmission. European Collaborative Study. Lancet 1991; 337(8736):253–60
- Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331 (18): 1173–80
- Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 1995; 333(5):298–302
- Bryson YJ, Luzuriaga K, Sullivan JL, et al. Proposed definitions for in utero versus intrapartum transmission of HIV-1. (Letter) N Engl J Med 1992; 327(17): 1246–7
- Palasanthiran P, Ziegler JB, Dwyer DE, et al. Early detection of human immunodeficiency virus type 1 infection in Australian infants at risk of perinatal infection and factors affecting transmission. Pediatr Infect Dis J 1994; 13(12): 1083–90
- Phuapradit W, Chaturachinda K, Saropala N, et al. Routine voluntary antenatal anti-HIV screening in Bangkok, Thailand. Aust N Z J Obstet Gynaecol 1995; 35(2): 168–72
- Selwyn PA, Carter RJ, Schoenbaum EE, et al. Knowledge of HIV antibody status and decisions to continue or terminate pregnancy among intravenous drug users. JAMA 1989; 261(24):3567–71
- Lindgren S, Bohlin AB, Forsgren M, et al. Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programme. BMJ 1993; 307(6917): 1447–51
- Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA 1991; 266(17):2419–29
- Dunn DT, Newell ML, Ades AE, et al. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340(8819):585–8
- Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HI V-1 infection predicted by the quantity of virus in plasma. Science 1996; 272(5265):1167–70
- Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nat Med 1996; 2(6):625–9
- Hamilton JD, Hartigan PM, Simberkoff MS, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the Veterans Affairs Cooperative Study. N Engl J Med 1992; 326(7):437–43
- Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994; 343 (8902):871–81
- McCusker J, Stoddard AM, Mayer KH, et al. Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men. Am J Public Health 1988; 78(4):462–7
- Fox R, Odaka NJ, Brookmeyer R, et al. Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS 1987; 1(4):241–6
- Italian Collaborative Study Group of HIV Prevalence in Newborns. Anti-HIV 1 antibodies prevalence in parturients through newborn testing: results of the Italian anonymous serosurvey. Eur J Epidemiol 1993; 9(4):430–5
- Lo B. Resolving ethical dilemmas: a guide for clinicians. Baltimore: Williams & Wilkins, 1995
- Bayer R. Ethical challenges posed by zidovudine treatment to reduce vertical transmission of HIV. (Editorial) N Engl J Med 1994; 331(18):1223–5
- Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection: Multicenter AIDS Cohort Study. JAMA 1993; 270(21):2563–7
- Centers for Disease Control and Prevention. Birth outcomes following zidovudine therapy in pregnant women. JAMA 1994; 272(1):17
- Sperling RS, Stratton P, O'Sullivan MJ, et al. A survey of zidovudine use in pregnant women with human immunodeficiency virus infection. N Engl J Med 1992; 326(13):857–61
- Schwartz JS, Dans PE, Kinosian BP. Human immunodeficiency virus test evaluation, performance, and use: proposals to make good tests better. JAMA 1988; 259(17):2574–9
- Wong JG, Feussner JR. Screening for HIV infection: the time has not yet come. N C Med J 1994; 55(6):212–6
- Meyer KB, Pauker SG. Screening for HIV: can we afford the false positive rate? N Engl J Med 1987; 317(4):238–41
- Bayer R, Stryker J, Smith MD. Testing for HIV infection at home. N Engl J Med 1995; 332(19):1296–9
- Phillips KA, Flatt SJ, Morrison KR, et al. Potential use of home HIV testing. N Engl J Med 1995; 332(19):1308–10